Tag: drug development

Basophil Activation Testing – Standardized

3 Reasons to Consider this Method in Kinase Inhibitor Drug Development Basophils are the circulating immune cells that participate in allergic reactions and share many of the signaling pathways that are also present in other types of immune cells that may develop into blood cancers or participate in the development of autoimmune disorders. Therefore, measuring

BUHLMANN Flow CAST Kinase Inhibition Assay and Utilization in Research

BÜHLMANN's Kinase Inhibition Assay has been utilized in several publications in various fields of study such as drug discovery, cancer research, autoimmune disease research, and more. Several key kinases that are molecular targets in drug discovery, such as PI3Kγ and PI3Kδ, SYK, BTK are main components in the basophil activation signaling pathways. Our Assay has been

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.

Tag: drug development

Basophil Activation Testing – Standardized

BUHLMANN Flow CAST Kinase Inhibition Assay and Utilization in Research

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US